Sunflower: Announcement on Resolutions of the 2024 Fourth Extraordinary General Meeting of Shareholders
Sunflower: Announcement of Resolutions of the Fourth Meeting of the Sixth Board of Directors
Sunflower: Legal Opinion of Shanghai AllBright Law Firm on the 2024 Fourth Extraordinary General Meeting of Shareholders of Zhejiang Sunflower Health Technology Co., Ltd.
Sunflower: Notice on Convening the Fourth Extraordinary General Meeting of Shareholders in 2024
Sunflower: Announcement on the Resignation of the Chairman and the By-election of Non-Independent Directors
Sunflower: Announcement of Resolutions of the Third Meeting of the Sixth Board of Directors
Sunflower: Announcement on changes in the subsidiary\'s pharmaceutical production license
Sunflower: Third quarter report 2024
Sunflower: Announcement on the subsidiary\'s participation in the fifth batch of centralized drug volume procurement in Fujian Province to be selected
Sunflower: Announcement of Resolutions of the First Meeting of the 6th Board of Supervisors
Sunflower: Legal Opinion of Shanghai AllBright Law Firm on the 2024 Third Extraordinary General Meeting of Shareholders of Zhejiang Sunflower Health Technology Co., Ltd.
Sunflower: Announcement on the adjustment of staff representative supervisors of the 6th Board of Supervisors
Sunflower: Announcement on Resolutions of the 2024 Third Extraordinary General Meeting of Shareholders
Sunflower: Announcement of Resolutions of the First Meeting of the 6th Board of Directors
Sunflower: An indicative announcement on issuing shares to specific targets and restricting the listing and circulation of shares
Sunflower: Verification opinion of Zheshang Securities Co., Ltd. on the listing and circulation of shares issued by Zhejiang Sunflower Health Technology Co., Ltd. to specific targets and restricted shares
Sunflower: Announcement on the Election of Staff Representative Supervisors for the 6th Board of Supervisors
Sunflowers: 2024 Semi-Annual Report
Sunflower: 2024 Semi-Annual Report Summary
Sunflower: Zheshang Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Zhejiang Sunflower Health Technology Co., Ltd.